Results 101 to 110 of about 3,695 (214)

The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?

open access: yesJournal of Translational Medicine, 2017
Spondylarthritis (SpA) is an inflammatory rheumatic disease associated with increased incidence of major adverse cardiovascular events (MACEs). Recently, Paramarta et al. proposed the use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis to
Loukman Omarjee   +2 more
doaj   +1 more source

Use of aceclofenac (aertal) in back pain

open access: yesСовременная ревматология, 2011
Back pain is a generalized type of locomotor lesion that is caused by soft tissue pathology and degenerative changes in the vertebral column in most cases and by intervertebral disk herniation, spinal stenosis, compression fractures in osteoporosis, by ...
Yuliya Leonidovna Korsakova   +1 more
doaj   +1 more source

Late-onset ankylosing spondylitis and spondylarthritis: an update on clinical manifestations, differential diagnosis and pharmacological therapies.

open access: yes, 2010
International audienceAnkylosing spondylitis (AS) and spondylarthritis (SpA) are generally observed in young male patients but can be diagnosed in the elderly. These cases correspond to late-onset or late-diagnosed AS or SpA.
Toussirot, Eric
core   +1 more source

Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis

open access: yes, 2012
<b>Objective</b><p></p> In rats transgenic for human HLA–B27 and β2-microglobulin (B27-transgenic rats), colitis and peripheral inflammation develop spontaneously.
Pamela Wright   +13 more
core   +1 more source

Absence of a Classically Activated Macrophage Cytokine Signature in Peripheral Spondylarthritis, Including Psoriatic Arthritis

open access: yes, 2009
Objective. Peripheral spondylarthritis (SpA) is characterized by macrophages that express CD163, a marker of alternative activation (M2). The purpose of this study was to assess whether this differential infiltration with macrophage subsets was ...
Tak, Paul P.   +9 more
core   +1 more source

The New ASAS Classification Criteria For Axial And Peripheral Spondylarthritis: Valid In The Latin American Patients, But

open access: yes, 2010
2 páginasBackground: Different Spondylarthritis (SpA) presentation pattern have been described in Latin American countries. The Undiferentiated Spondylarthritis (uSpA) and Reactive Arthritis (ReA) forms are frequent (about 75%), whereas Ankylosing ...
Calvo Páramo, Enrique   +3 more
core  

Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis

open access: yes, 2007
Objective. To study the relationship between inflammation and remodeling by inhibiting tumor necrosis factor alpha (TNF alpha) in male DBA/1 mice with spontaneous arthritis, a model of spondylarthritis (SpA). Methods.
De Bari, C   +3 more
core   +1 more source

Transthoracic Echocardiography findings in patients with Ankylosing Spondylitis in Kurdistan region

open access: yesAdvanced Medical Journal
Background and objectives: Ankylosing spondylitis is a chronic inflammatory disorder that affecting axial and non-axial joints leads to a loss of mobility and function over time.
Elaf Kamal Abdulwahab   +1 more
doaj   +1 more source

Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis

open access: yes, 2006
OBJECTIVE: To characterize the synovial immunopathologic features of juvenile-onset spondylarthritis (SpA) in relation to adult SpA and other forms of juvenile idiopathic arthritis (JIA).
Joos, Rik   +9 more
core   +1 more source

Clinical, laboratory and imaging features in spondylarthritis linked to Chlamydia trachomatis: molecular diagnosis and evolution [PDF]

open access: yes
Introducere. Chlamydia trachomatis este un factor important în declanşarea artritei reactive şi a spondiloartritelor seronegative, cu implicare posibilă şi în artrita reumatoidă. Profilurile clinice, diagnostice şi eficienţa tratamentelor an-tibacteriene
Groppa, Liliana   +5 more
core  

Home - About - Disclaimer - Privacy